Literature DB >> 11826013

Detection of rpoB mutations in Mycobacterium tuberculosis with LightCycler technology.

Maria J Torres, Antonio Criado, Jose C Palomares, Javier Aznar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11826013      PMCID： PMC153994          DOI： 10.1128/JCM.40.2.735.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis.

Authors:  K J Edwards; L A Metherell; M Yates; N A Saunders
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.

Authors:  M J Torres; A Criado; J C Palomares; J Aznar
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.

Authors:  L E Lindler; W Fan; N Jahan
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates.

Authors:  R A Walker; N Saunders; A J Lawson; E A Lindsay; M Dassama; L R Ward; M J Woodward; R H Davies; E Liebana; E J Threlfall
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

5.  Characterization of rifampin-resistance in pathogenic mycobacteria.

Authors:  D L Williams; C Waguespack; K Eisenach; J T Crawford; F Portaels; M Salfinger; C M Nolan; C Abe; V Sticht-Groh; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.